| Invitae is in the business of delivering genetic testing services that support a lifetime of patient care from inherited disease diagnoses, to family planning, to proactive health screening to personalized diagnosis, treatment and monitoring of cancer. Those tests are delivered via a platform that serves patients, healthcare providers, biopharma companies and other partners, thereby capturing the potential of genetics and helping to expand its use across the healthcare continuum. Co. applies proprietary design, process automation, robotics and bioinformatics software solutions to achieve efficiencies in sample processing and variant interpretation, allowing medical interpretation at scale. We show 30 historical shares outstanding datapoints in our NVTA shares outstanding history coverage, used to compute NVTA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NVTA market cap history over the course of time is important for investors
interested in comparing NVTA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NVTA versus a peer is one thing; comparing
NVTA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NVTA can fluctuate over the course of history.
With this page we aim to empower investors researching NVTA by allowing them to research the NVTA market cap history.